On this page
MKS1
MKS transition zone complex subunit 1
MKS1 is located on the long (q) arm of chromosome 17, at band 17q22. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 17 in the library →Available at Jeen Health
Clinical tests that include this
Overview
MKS1 is located on chromosome 17 at position q22 and encodes a protein of 559 amino acids. The protein functions as part of a multi-component complex at the base of primary cilia, antenna-like structures that project from most cells in the body. Primary cilia serve as signalling hubs, detecting chemical and mechanical signals from the surrounding environment and relaying information into the cell.
When MKS1 does not function properly, the transition zone fails to assemble correctly, disrupting ciliary signalling pathways critical for embryonic development. This leads to severe congenital abnormalities affecting the brain, kidneys, liver, and limbs. The gene is inherited in an autosomal recessive pattern, meaning pathogenic variants must be present on both copies of the gene for disease to manifest.
What the gene does
The MKS1 protein localises to the ciliary transition zone, a cylindrical region at the base of the cilium that acts as a selective barrier controlling which molecules enter the ciliary compartment. This gatekeeper function is essential for maintaining the unique protein and lipid composition of the ciliary membrane, which in turn allows the cilium to function as a signalling organelle.
MKS1 forms part of a larger protein network known as the MKS transition zone complex, which includes other ciliopathy-associated proteins. Together, these components create Y-shaped structures that connect the ciliary membrane to the underlying axoneme, the microtubule-based scaffold of the cilium. By maintaining this structural integrity, MKS1 enables proper ciliary signalling during development, particularly for pathways involved in left-right patterning, limb formation, and neural tube closure. When the transition zone is compromised, developmental signalling cascades such as the Hedgehog and Wnt pathways are disrupted, leading to the multi-organ defects characteristic of ciliopathies.
Video: Genetics 101
Chromosome location
MKS1 is positioned on the long arm of chromosome 17 at band q22, a region spanning approximately 55 million to 59 million base pairs from the chromosome's short-arm end. The genomic locus contains 18 exons that together encode the full-length protein. The gene spans roughly 11 kilobases of chromosomal DNA.
Protein structure
The MKS1 protein comprises 559 amino acids and contains a C2 B9-type domain spanning amino acids 311 to 439. This domain is a calcium-independent lipid-binding motif that may facilitate the protein's association with ciliary membranes. The C2 B9-type fold is characterised by a beta-sandwich structure that can interact with phospholipids, potentially anchoring MKS1 to the specialised membrane environment of the transition zone. Additional regions of the protein mediate interactions with other transition zone components, though detailed structural characterisation of these interfaces remains an active area of research.
Key variants
Pathogenic variants in MKS1 are distributed throughout the gene, with no single dominant hotspot accounting for the majority of cases. Loss-of-function variants, including nonsense and frameshift changes that lead to premature protein truncation, are commonly observed. Missense variants affecting conserved residues within the C2 B9-type domain or other functionally critical regions can also abolish protein function, preventing proper transition zone assembly.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1024+1G>T | - | Pathogenic | ★★☆☆ | Meckel syndrome, type 1 |
c.1045C>T | p.Gln349Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.1058del | p.Gly353fs | Pathogenic | ★★☆☆ | Joubert syndrome |
c.1074C>A | p.Cys358Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.119_126dup | p.Pro43fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.1408-14A>G | - | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome 28 |
c.149del | p.Asp50fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.633del | p.Tyr213fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.812dup | p.His271fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.81_82del | - | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
MKS1 variants are primarily associated with Meckel-Gruber syndrome, a severe autosomal recessive ciliopathy typically lethal in the perinatal period. Affected individuals present with a characteristic triad of occipital encephalocele, postaxial polydactyly, and cystic kidney dysplasia, though additional features such as hepatic fibrosis and cleft palate may also occur. The disorder arises because defective transition zone function disrupts multiple developmental signalling pathways simultaneously, leading to malformations in organs that rely heavily on ciliary signalling during embryogenesis. Some variants may occasionally be associated with milder or overlapping ciliopathy phenotypes, reflecting partial retention of protein function.
Inheritance pattern
Conditions caused by pathogenic MKS1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
MKS1 holds green classification status on multiple NHS Genomic Medicine Service gene panels, reflecting robust evidence for its clinical validity. These panels include Bardet Biedl syndrome (R107), Clefting, DDG2P, Fetal anomalies (R21), Intellectual disability (R29), Limb disorders, Neurological ciliopathies, Ophthalmological ciliopathies, Rare multisystem ciliopathy disorders, Renal ciliopathies, Retinal disorders (R32), Severe early-onset obesity (R149), and Skeletal dysplasia (R104). This broad panel representation underscores the pleiotropic effects of MKS1 dysfunction across multiple organ systems and the importance of the gene in prenatal and postnatal genetic testing pathways.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What inheritance pattern does MKS1 follow?
MKS1 variants are inherited in an autosomal recessive manner. An individual must inherit one pathogenic variant from each parent to develop Meckel-Gruber syndrome. Carriers, who have one pathogenic variant and one working copy, typically do not show symptoms.
How do MKS1 variants cause developmental abnormalities?
Pathogenic MKS1 variants disrupt the ciliary transition zone, impairing the cilium's ability to function as a signalling centre during embryonic development. This disrupts critical pathways that guide organ formation, leading to brain, kidney, liver, and limb malformations.
Is MKS1 included in NHS genomic testing?
Yes, MKS1 appears on numerous NHS gene panels with green classification status, including panels for foetal anomalies, renal ciliopathies, and neurological ciliopathies. This enables diagnostic testing for suspected ciliopathy cases through the NHS Genomic Medicine Service.